Renagel (DOH CENTRAL PHARMACY)
Welcome to the PulseAid listing for the Renagel drug offered from DOH CENTRAL PHARMACY. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | DOH CENTRAL PHARMACY |
NON-PROPRIETARY NAME: | Renagel |
SUBSTANCE NAME: | SEVELAMER HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
Renagel HUMAN PRESCRIPTION DRUG Details:
Item Description | Renagel from DOH CENTRAL PHARMACY |
LABELER NAME: | DOH CENTRAL PHARMACY |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 800(mg/1) |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53808-0777_5ec67fac-794f-4ca5-a5ef-6a0cf51565e0 |
PRODUCT NDC: | 53808-0777 |
APPLICATION NUMBER: | NDA021179 |
Other SEVELAMER HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: